Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase
Xiaoyu Zeng(Huazhong University of Science and Technology), Qiuhong Duan(Huazhong University of Science and Technology)
Cited by 74